Receptor Profile
Receptor Actions
History & Culture
1500 BCE–900 CE
Ayahuasca has been used by the indigenous peoples of South America since before recorded history. The word itself derives from Quechuan languages spoken in the Andes, with its name translating to "spirit rope" or "liana of the soul," referring both to the Banisteriopsis caapi vine and the psychoactive brew prepared from it. Archaeological evidence suggests the use of psychoactive plants in the northeastern Amazon dates back to 1500–2000 BCE. Artifacts from this period include anthropomorphic figurines, snuffing trays, and pottery vessels adorned with mythological figures and sacred animals, offering glimpses into pre-Columbian ritual culture. More direct evidence of B. caapi use emerged from a pouch discovered in a cave in southwestern Bolivia in 2008, while chemical traces of harmine were identified in the hair of two mummies found in northern Chile. Both findings have been linked to the Tiwanaku civilization, dating to approximately 900 CE. By the 19th century, the specific ritual use of ayahuasca was widespread among Indigenous groups throughout the Amazon and Orinoco basins, though its precise origins remain uncertain.
17th century–present
The first Western references to the ayahuasca beverage appeared during the 17th century, coinciding with the European colonization of the Americas. The earliest known report is a letter from Vicente de Valverde to the Holy Office of the Inquisition. Jose Chantre y Herrera, also writing in the 17th century, provided the first detailed description of what he termed a "devilish potion" prepared from bitter herbs and lianas (referred to as ayaguasca), along with accounts of its associated rituals. Christian missionaries from Spain and Portugal who encountered ayahuasca during this period predictably characterized it as the work of the devil, establishing a pattern of colonial suspicion toward indigenous plant medicines that would persist for centuries.
Throughout its history, ayahuasca has been employed across diverse South American cultures for spiritual, social, and medicinal purposes. Traditional preparation involves a ritualistic, multi-day process of macerating and boiling B. caapi with other plants such as Psychotria viridis. These ceremonies are typically guided by shamans and involve specific dietary restrictions and ritual practices that have evolved over generations to support the psychological and spiritual dimensions of the experience. The Shipibo-Konibo people of the Peruvian Amazon have played a particularly significant historical and cultural role in the development and preservation of ayahuasca traditions. Among those who undergo the ayahuasca experience, reports of profound spiritual revelations regarding one's purpose, the nature of existence, and personal insight are common, with many describing lasting positive changes following their encounters with the brew.
mid-20th century–present
Ayahuasca spread beyond its traditional Amazonian context by the mid-20th century, primarily through syncretic religious movements originating in Brazil. These organizations blended indigenous ayahuasca practices with Christian and other spiritual traditions, establishing formal churches that would eventually carry the brew to Europe, North America, and beyond. The contemporary ayahuasca landscape includes both traditional indigenous ceremonial use and participation in organized religious contexts, as well as a growing phenomenon of ayahuasca tourism, with retreat centers operating throughout South America offering ceremonial experiences to international visitors.
Subjective Effect Notes
physical: The physical effects of Ayahuasca can be broken down into three main components all of which progressively intensify proportional to dosage.
cognitive: The head space of ayahuasca is described by many as extremely sober and clear headed in its style when compared to other commonly used psychedelics such as LSD or Psilocin. This is despite the fact that it contains a large number of psychedelic typical and unique cognitive effects.
Effect Profile
Curated + 166 ReportsStrong visuals, headspace, auditory effects, and body load
Strong sensory enhancement, empathy, euphoria, and stimulation
Strong anxiety/jitters and focus with moderate stimulation and euphoria
Duration Timeline
BluelightTolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Cross-Tolerances
Demographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
Erowid + BluelightEffects aggregated from 166 experience reports (141 Erowid + 25 Bluelight)
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 45
Adverse Effects 35
Subjective Effect Ontology
Experience ReportsStructured effect tags extracted from 166 Erowid & Bluelight experience reports using a controlled vocabulary of 220+ canonical effects across 15 domains.
Gastrointestinal
Real-World Dose Distribution
62K DosesFrom 160 individual dose entries
Form / Preparation
Most common forms and preparations reported
Body-Weight Dosing
Dose relative to body weight from reports with weight data
Redose Patterns
Redosing behavior across 112 reports
Legal Status
| Country | Status | Notes |
|---|---|---|
| Brazil | Legal for religious use | Religious use was legalized following two official government inquiries in the mid-1980s, which concluded that ayahuasca is not a recreational drug and has valid spiritual applications. Brazil is the origin of the Santo Daime and União do Vegetal syncretic religious movements. |
| Canada | DMT is Schedule III CDSA; harmaline is Schedule III; religious exemptions available | DMT and harmaline are both controlled under the Controlled Drugs and Substances Act. However, in 2017, the Santo Daime Church Céu do Montréal received a religious exemption permitting the use of ayahuasca as a sacrament in their rituals. |
| France | Schedule I (Stupéfiants) | In early 2005, Santo Daime initially won a court case permitting use of the tea, as they did not perform chemical extractions and the plants were not scheduled. However, four months later, the common botanical ingredients of ayahuasca along with harmala alkaloids were declared stupéfiants (narcotic Schedule I substances), making the tea and its ingredients illegal to possess or use. As of 2005, nearly all DMT-containing plants that could be used in ayahuasca preparations became controlled. |
| Netherlands | Legal for religious use (case law precedent) | The first ayahuasca churches affiliated with Brazilian Santo Daime were established here. In 2001, the Amsterdam district court ruled in favor of Santo Daime leaders Hans Bogers and Geraldine Fijneman, finding that the prosecution could not demonstrate sufficient threat to public health and order to justify denying religious freedom under ECHR Article 9. This verdict established an important legal precedent, and various ayahuasca groups have since operated in the country. |
| Peru | Legal; protected cultural heritage | Ayahuasca is legal and formally protected as part of the nation's cultural heritage. When ratifying the 1971 Convention on Psychotropic Substances, Peru entered a reservation excluding Ayahuasca and San Pedro from international control, citing traditional ritual use by Amazonian peoples. On 24 June 2008, the Instituto Nacional de Cultura declared the traditional knowledge and ceremonial use of ayahuasca by Indigenous communities as Patrimonio Cultural de la Nación (Cultural Heritage of the Nation). |
| United States | Schedule I (DMT component); religious exemptions available | DMT is a Schedule I controlled substance under federal law, making ayahuasca brews technically illegal. However, the plants themselves contain no scheduled chemicals and remain legal. Religious organizations have obtained legal exemptions under the Religious Freedom Restoration Act, including the União do Vegetal (Supreme Court ruling in Gonzales v. O Centro Espírita Beneficente União do Vegetal, 2006) and Santo Daime (District Court ruling, 2009). Several municipalities have decriminalized natural entheogens including Oakland, California (June 2019), Santa Cruz, California (January 2020), and Ann Arbor, Michigan (September 2020). |
References
Cited References
- Alcohol and Drug Foundation: Ayahuasca
- Callaway et al. 1999 - Pharmacokinetics of Hoasca alkaloids in healthy humans
- Erowid: Ayahuasca Vault
- Erowid: Ayahuasca Analogues and Pharmahuasca
- Erowid: DMT Freebase Content in Ayahuasca/Pharmahuasca Preparations
- McKenna et al. 1998 - Scientific Investigation of Ayahuasca
- Nichols 2016 - Psychedelics
- Osório et al. 2015 - Antidepressant effects of a single dose of ayahuasca
- Palhano-Fontes et al. 2019 - Rapid antidepressant effects of ayahuasca
- PsychonautWiki: Ayahuasca
- PsychonautWiki: Harmala alkaloid
- PsychonautWiki: Peganum harmala
- Santos et al. 2013 - Safety and side effects of ayahuasca in humans
- TripSit: Drug Combination Chart
- TripSit Factsheet: DMT
- TripSit Wiki: Ayahuasca